Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avichai Shimoni

Showing results (91-100 of 165) with videos related to

Pageof 17
Sort By:
Oncotarget|December 7, 2017
Dissecting the mechanisms involved in anti-human T-lymphocyte immunoglobulin (ATG)-induced tolerance in the setting of allogeneic stem cell transplantation - potential implications for graft versus host diseaseKatia Beider, David Naor, Valeria Voevoda, et al.
Journal of Clinical Immunology|October 8, 2011
Anti-T lymphocyte globulin (ATG) induces generation of regulatory T cells, at least part of them express activated CD44Orly Shimony, Arnon Nagler, Yechiel N Gellman, et al.
Blood|October 27, 2005
BCL6 is regulated by p53 through a response element frequently disrupted in B-cell non-Hodgkin lymphomaOfer Margalit, Hila Amram, Ninette Amariglio, et al.
Blood Advances|October 13, 2021
Origins of bloodstream infections following fecal microbiota transplantation: a strain-level analysisAdi Eshel, Itai Sharon, Arnon Nagler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 1, 2014
Autologous transplantation for transformed non-Hodgkin lymphoma using an yttrium-90 ibritumomab tiuxetan conditioning regimenMatthew Mei, Marielle J Wondergem, Joycelynne M Palmer, et al.
Oncotarget|June 25, 2020
Reassessing the role of high dose cytarabine and mitoxantrone in relapsed/refractory acute myeloid leukemiaJonathan Canaani, Meital Nagar, Gabriel Heering, et al.
Plos One|March 5, 2016
Prediction of Hematopoietic Stem Cell Transplantation Related Mortality- Lessons Learned from the In-Silico Approach: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party Data Mining StudyRoni Shouval, Myriam Labopin, Ron Unger, et al.
Cancer|March 23, 2017
Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Dietrich Beelen, et al.
British Journal of Haematology|November 17, 2009
Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantationNicolaus Kröger, Avichai Shimoni, Georgia Schilling, et al.
Oncotarget|November 24, 2016
Immunological effects of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or philadelphia chromosome-positive acute lymphoblastic leukemiaNira Varda-Bloom, Ivetta Danylesko, Roni Shouval, et al.
Pageof 17

Showing results (91-100 of 165) with videos related to

Sort By:
Pageof 17
Oncotarget|December 7, 2017
Dissecting the mechanisms involved in anti-human T-lymphocyte immunoglobulin (ATG)-induced tolerance in the setting of allogeneic stem cell transplantation - potential implications for graft versus host diseaseKatia Beider, David Naor, Valeria Voevoda, et al.
Journal of Clinical Immunology|October 8, 2011
Anti-T lymphocyte globulin (ATG) induces generation of regulatory T cells, at least part of them express activated CD44Orly Shimony, Arnon Nagler, Yechiel N Gellman, et al.
Blood|October 27, 2005
BCL6 is regulated by p53 through a response element frequently disrupted in B-cell non-Hodgkin lymphomaOfer Margalit, Hila Amram, Ninette Amariglio, et al.
Blood Advances|October 13, 2021
Origins of bloodstream infections following fecal microbiota transplantation: a strain-level analysisAdi Eshel, Itai Sharon, Arnon Nagler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 1, 2014
Autologous transplantation for transformed non-Hodgkin lymphoma using an yttrium-90 ibritumomab tiuxetan conditioning regimenMatthew Mei, Marielle J Wondergem, Joycelynne M Palmer, et al.
Oncotarget|June 25, 2020
Reassessing the role of high dose cytarabine and mitoxantrone in relapsed/refractory acute myeloid leukemiaJonathan Canaani, Meital Nagar, Gabriel Heering, et al.
Plos One|March 5, 2016
Prediction of Hematopoietic Stem Cell Transplantation Related Mortality- Lessons Learned from the In-Silico Approach: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party Data Mining StudyRoni Shouval, Myriam Labopin, Ron Unger, et al.
Cancer|March 23, 2017
Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Dietrich Beelen, et al.
British Journal of Haematology|November 17, 2009
Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantationNicolaus Kröger, Avichai Shimoni, Georgia Schilling, et al.
Oncotarget|November 24, 2016
Immunological effects of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or philadelphia chromosome-positive acute lymphoblastic leukemiaNira Varda-Bloom, Ivetta Danylesko, Roni Shouval, et al.
Pageof 17